Abstract:Depression is accompanied by an increase in activity in the amygdala and a decrease in the rostral anterior cingulate cortex (rACC), with the former attributed to a failure of the latter to exert its normal inhibitory influence. This failure is likely due to regression of synaptic connections between the rACC and the amygdala, a process reversed in part by selective serotonin reuptake inhibitors (SSRIs). The present work presents a hypothesis as to how SSRIs might bring about this process and hence normalization of activity, at least in patients that are responsive to SSRIs. Serotonin receptors of the excitatory 5-HT 2A R class increase N-methyl-D-aspartate receptor (NMDAR) efficacy, while those of the inhibitory 5-HT 1A R class decrease NMDAR efficacy. A decrease of 5-HT transporter (5-HTT) efficacy, either during human development through functional polymorphisms, or in animals through 5-HTT transgenic knockouts, is accompanied by a decrease in 5-HT 1A R and hence an increase in excitability and NMDAR efficacy which drives an increase in synaptic spines in the amygdala. As the limbic region of the brain normally possesses high levels of 5-HT 1A R the effect of loss of these is to increase excitation in this region, as is observed. Changes in the level of extracellular 5-HT in adult animals also modulates the density of synaptic spines, with these increasing with an increase in 5-HT, possibly as a consequence of increases in 5-HT 2A R activity over that of 5-HT 1A R. Increasing extracellular levels of 5-HT with SSRIs would then lead to an increase in excitability and in synaptic spines for afferents in the dorsal rostral anterior cingulate cortex but not in the ventral regions such as the amygdala that have few 5-HT 2A R. This allows dorsal regions to once more exert their inhibitory influence over ventral regions. In this way, SSRIs may exert their effect in normalizing dorsal hypometabolism and ventral hypermetabolism in those suffering from depression.

Synaptic plasticity in depression: molecular, cellular and functional correlates

Changed Synaptic Plasticity in Neural Circuits of Depressive-Like and Escitalopram-Treated Rats

Effects of Chronic Mild Stress Induced Depression on Synaptic Plasticity in Mouse Hippocampus

Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model

Phytochemicals That Act on Synaptic Plasticity as Potential Prophylaxis against Stress-Induced Depressive Disorder

Frontal lobe synaptic plasticity in development and disease: modulation by the dopamine D1 receptor

Synaptic plasticity and depression: the role of miRNAs dysregulation

Synaptic plasticity-related neural oscillations on hippocampus–prefrontal cortex pathway in depression

Occlusion of dopamine-dependent synaptic plasticity in the prefrontal cortex mediates the expression of depressive-like behavior and is modulated by ketamine

Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Synapse Regression in Depression: The Role of 5-HT Receptors in Modulating NMDA Receptor Function and Synaptic Plasticity

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice

Studying synaptic plasticity in the human brain and opportunities for drug discovery

Impairments of Behavior, Information Flow Between Thalamus and Cortex, and Prefrontal Cortical Synaptic Plasticity in an Animal Model of Depression

Microglia-dependent excessive synaptic pruning leads to cortical underconnectivity and behavioral abnormality following chronic social defeat stress in mice

Chronic psychosocial stress triggers microglial-/macrophage-induced inflammatory responses leading to neuronal dysfunction and depressive-related behavior

Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications

Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications

A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists